Back to Journals » ClinicoEconomics and Outcomes Research » Volume 1
Management strategies and cost effectiveness in the prevention of cervical cancer
Authors Prasad S
Published 5 June 2009 Volume 2009:1 Pages 17—23
DOI https://doi.org/10.2147/CEOR.S4226
Review by Single anonymous peer review
Peer reviewer comments 3
Smita R Prasad
University of Kentucky, College of Public Health, Lexington, KY, USA
Abstract: This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism.
Keywords: cervical cancer, human papillomavirus, HPV
© 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.